CytRx Corporation (OTCQB:CYTR) (“CytRx” or the “Company”), a specialized biopharmaceutical company focused on research and development for the oncology and
Read more
Englewood Cliffs, NJ, Jan. 11, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on
Read moreMONTREAL, QC–(Marketwired – May 11, 2016) – Sunshine Biopharma Inc. (OTCQB: SBFM), a pharmaceutical company focused on the research, development and
Read more
BERKELEY, Calif., and VANCOUVER, British Columbia, April 27, 2020 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF), a
Read more
VANCOUVER, British Columbia (Uptick Newswire – September 26, 2017) – Jeffery Bacha, CEO of DelMar Pharmaceuticals Inc. (NASDAQ:DMPI) interviews on the
Read more
Coral Springs, FL (Uptick Newswire – August 24, 2017) – CNA Finance Chief Research Analyst, Kenny Soulstring, today announced that
Read more
EL PASO, TX,. (Uptick Newswire – July 17, 2017) – Greetings From The CEO and Staff at Premier Biomedical, (OTC:BIEI)!
Read more
BATON ROUGE, LA–(Uptick Newswire – July 13, 2017) – OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) (“OncBioMune” or the “Company”), a revenue-stage biopharmaceutical company engaged
Read more
El Paso, Texas, (Uptick Newswire – June 29, 2017) – Premier Biomedical, Inc. (OTCQB: “BIEI“) announced today that it has
Read more
TORONTO, ON., (Uptick Newswire – Jun 26, 2017) – Easton Pharmaceuticals, Inc. (OTC: EAPH), is pleased to announce it has
Read more
REDONDO BEACH, CA – (Uptick Newswire – February 9, 2017) – SECFilings.com, a leading financial news and information portal offering
Read more
Patient Received Permission to Be Treated with RSHO-X™ for Pain Associated with Cancer Treatment and General Well-Being SAN DIEGO, CA
Read more